Correlation of Lymphocyte Count with Treatment Response to Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

被引：0

作者：

Sasaki, Koji ^{[1
]}

Rodriguez-Rivera, Ildefonso Ismael ^{[2
]}

Kantarjian, Hagop M. ^{[1
]}

O'Brien, Susan ^{[1
]}

Jabbour, Elias ^{[1
]}

Borthakur, Gautam ^{[1
]}

Ravandi, Farhad ^{[1
]}

Burke, Michael J. ^{[3
]}

Zweidler-McKay, Patrick A. ^{[1
]}

Cortes, Jorge E. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ Texas Southwestern, Austin, TX USA

[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] New tyrosine kinase inhibitors in chronic myeloid leukemia
Kantarjian, Hagop
Cortes, Jorge
CANCER INVESTIGATION, 2007, 25 : 41 - 43
[42] The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting
Di Bella, Nicholas J.
Bhowmik, Debajyoti
Bhor, Menaka
Yap, Mark
Middlebrook, Brooke
Rembert, Debra
Cain, Zachary
Okoro, Tony
Bolinder, Bjorn
Patt, Debra
Jabbour, Elias J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (10): : 599 - 605
[43] Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
Sasaki, Koji
Kantarjian, Hagop M.
Jain, Preetesh
Jabbour, Elias J.
Ravandi, Farhad
Konopleva, Marina
Borthakur, Gautam
Takahashi, Koichi
Pemmaraju, Naveen
Daver, Naval
Pierce, Sherry A.
O'Brien, Susan M.
Cortes, Jorge E.
CANCER, 2016, 122 (02) : 238 - 248
[44] Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia
Lomaia, Elza
Zaritskey, Andrey
Shuvaev, Vasily
Martynkevich, Irina
Fominykh, Mikhail
Ovsyannikova, Ekaterina
Lazorko, Natalia
Matyuhina, Natalia
Butylin, Pavel
Machyulaitene, Elena
Salamatova, Evgenia
Abdulkadyrov, Kudrat
BLOOD, 2015, 126 (23)
[45] Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
Nesr, George
Claudiani, Simone
Milojkovic, Dragana
Innes, Andrew
Fernando, Fiona
Caballes, Irene
Mungozi, Patience
Szydlo, Richard
Lovato, Silvia
Jayasena, Channa
Apperley, Jane
LEUKEMIA & LYMPHOMA, 2024, 65 (08) : 1161 - 1166
[46] Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life
Norwood, James
Pastoret, Cedric
Luycx, Odile
Le Coz, Marie-Francoise
Moreau, Philippe
Trebouet, Adrien
Niault, Mathilde
Launay, Vincent
Allangba, Olivier
Bareau, Benoit
Doncker, Violaine
Grulois, Isabelle
Jacomy, Dominique
Le Du, Katell
Henry, Catherine
Le Pabic, Estelle
Boulland, Marie-Laure
Fest, Thierry
Lamy, Thierry
Escoffre-Barbe, Martine
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (10) : E329 - E331
[47] Novel tyrosine kinase inhibitors for patients with inadequate response in chronic myeloid leukemia
Mauro, Michael J.
CURRENT OPINION IN HEMATOLOGY, 2019, 26 (02) : 119 - 123
[48] Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia
Clark, Samantha E.
Marcum, Zachary A.
Radich, Jerald P.
Bansal, Aasthaa
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) : 1842 - 1852
[49] Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors
Gugliotta, Gabriele
Castagnetti, Fausto
Fogli, Miriam
Cavo, Michele
Baccarani, Michele
Rosti, Gianantonio
EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (05) : 563 - 574
[50] Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment
Chelysheva, Ekaterina
Turkina, Anna
Polushkina, Evgenia
Shmakov, Roman
Zeifman, Alexey
Aleshin, Sergey
Shokhin, Igor
Guranda, Dorel
Oksenjuk, Oksana
Mordanov, Sergey
Kazakbaeva, Khamida
Chilov, Ghermes
LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 733 - 738

← 1 2 3 4 5 →